AVBP
Price
$22.04
Change
-$0.60 (-2.65%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
934.4M
50 days until earnings call
Intraday BUY SELL Signals
OLMA
Price
$26.33
Change
+$0.19 (+0.73%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
2.1B
26 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AVBP vs OLMA

Header iconAVBP vs OLMA Comparison
Open Charts AVBP vs OLMABanner chart's image
ArriVent BioPharma
Price$22.04
Change-$0.60 (-2.65%)
Volume$11.49K
Capitalization934.4M
Olema Pharmaceuticals
Price$26.33
Change+$0.19 (+0.73%)
Volume$22.52K
Capitalization2.1B
AVBP vs OLMA Comparison Chart in %
AVBP
Daily Signal:
Gain/Loss:
OLMA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AVBP vs. OLMA commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVBP is a Hold and OLMA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (AVBP: $22.64 vs. OLMA: $26.14)
Brand notoriety: AVBP and OLMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVBP: 287% vs. OLMA: 74%
Market capitalization -- AVBP: $934.4M vs. OLMA: $2.1B
AVBP [@Biotechnology] is valued at $934.4M. OLMA’s [@Biotechnology] market capitalization is $2.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVBP’s FA Score shows that 1 FA rating(s) are green whileOLMA’s FA Score has 0 green FA rating(s).

  • AVBP’s FA Score: 1 green, 4 red.
  • OLMA’s FA Score: 0 green, 5 red.
According to our system of comparison, both AVBP and OLMA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVBP’s TA Score shows that 5 TA indicator(s) are bullish while OLMA’s TA Score has 2 bullish TA indicator(s).

  • AVBP’s TA Score: 5 bullish, 5 bearish.
  • OLMA’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, AVBP is a better buy in the short-term than OLMA.

Price Growth

AVBP (@Biotechnology) experienced а -2.06% price change this week, while OLMA (@Biotechnology) price change was +0.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Reported Earning Dates

AVBP is expected to report earnings on Mar 26, 2026.

OLMA is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OLMA($2.1B) has a higher market cap than AVBP($934M). AVBP YTD gains are higher at: 12.500 vs. OLMA (4.560). AVBP (-162.42M) and OLMA (-164.96M) have comparable annual earnings (EBITDA) . OLMA has more cash in the bank: 329M vs. AVBP (300M). AVBP has less debt than OLMA: AVBP (56K) vs OLMA (4.48M). AVBP (0) and OLMA (0) have equivalent revenues.
AVBPOLMAAVBP / OLMA
Capitalization934M2.1B45%
EBITDA-162.42M-164.96M98%
Gain YTD12.5004.560274%
P/E RatioN/AN/A-
Revenue00-
Total Cash300M329M91%
Total Debt56K4.48M1%
TECHNICAL ANALYSIS
Technical Analysis
AVBPOLMA
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 14 days ago
83%
Bullish Trend 21 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
AVBP
Daily Signal:
Gain/Loss:
OLMA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AATSX20.000.10
+0.50%
Ancora/Thelen Small-Mid Cap S
PEIZX24.920.11
+0.44%
PGIM Jennison Value Z
ICFAX9.09N/A
N/A
ICON Consumer Select Investor
MFRFX56.54-0.61
-1.07%
MFS Research A
HCMZX22.55-0.25
-1.10%
HCM Sector Plus R

AVBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVBP has been loosely correlated with VIR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if AVBP jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVBP
1D Price
Change %
AVBP100%
-0.15%
VIR - AVBP
50%
Loosely correlated
-0.39%
DNLI - AVBP
49%
Loosely correlated
-4.22%
SYRE - AVBP
47%
Loosely correlated
+1.65%
NUVL - AVBP
47%
Loosely correlated
+2.12%
XNCR - AVBP
47%
Loosely correlated
-0.99%
More

OLMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, OLMA has been loosely correlated with ARWR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if OLMA jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OLMA
1D Price
Change %
OLMA100%
+1.91%
ARWR - OLMA
43%
Loosely correlated
-1.18%
IPSC - OLMA
42%
Loosely correlated
N/A
NUVL - OLMA
42%
Loosely correlated
+2.12%
AVBP - OLMA
42%
Loosely correlated
-0.15%
EYPT - OLMA
42%
Loosely correlated
-3.69%
More